  | Decarnoncle, M., Marlier, H., Lhoir, F., Francois, L., Maréchal, L., Zwakhals, T., Juszczak, F., Decroo, C., Coppée, F., Tassin, A., Wattiez, R., & Decleves, A.-E. (01 December 2023). Organokine impact in obesity induced chronic kidney disease [Poster presentation]. GENDER DIFFERENCES IN RENAL DISEASE FOCUS ON DIABETES AND OBESITY, Garachico, Spain. |
 | Bah, K., Slavin, M., Claus, C., Decleves, A.-E., Kalisman, N., & Coppée, F. (15 June 2023). DUX4 protein interactors are involved in the DNA damage response [Paper presentation]. International Research Congress 2023, Milan, Italy. |
 | Claus, C., Slavin, M., Bah, K., Lancelot, C., Lassche, S., Fievet, M., Greco, A., Kusters, B., Decleves, A.-E., Van Engelen, B., Belayew, A., Kalisman, N., & Coppée, F. (09 June 2023). DUX4 and DUX4c directly interact with C1qBP in FSHD regenerating myofibers [Paper presentation]. International Research Congress. |
 | Slavin, M., Zohar, K., Claus, C., Linial, M., Decleves, A.-E., Coppée, F., & Kalisman, N. (09 June 2023). The Interactome of DUX4 Reveals an Inherent Feedback Mechanism by RFPL4 [Paper presentation]. International Research Congress, Milan, Italy. |
 | Claus, C., Slavin, M., Ansseau, E., Lancelot, C., Bah, K., Lassche, S., Fievet, M., Greco, A., Tomaiuolo, S., Tassin, A., Dudome, V., Kusters, B., Decleves, A.-E., Laoudj-Chenivesse, D., van Engelen, B. G. M., Nonclercq, D., Belayew, A., Kalisman, N., & Coppée, F. (07 March 2023). The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins. Skeletal Muscle, 13 (1), 5. doi:10.1186/s13395-022-00310-y  Peer Reviewed verified by ORBi |
Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (2023). Selection of peptides for a muscle-targeted delivery of ASO directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo [Paper presentation]. Physphar Spring meeting (2023), Brussels, Belgium. Editorial reviewed |
 | Tchéoubi, S. E. R., Akpovi, C. D., Coppée, F., Decleves, A.-E., Laurent, S., Agbangla, C., & Burtea, C. (November 2022). Molecular and cellular biology of PCSK9: impact on glucose homeostasis. Journal of Drug Targeting, 30 (9), 948 - 960. doi:10.1080/1061186X.2022.2092622 Peer Reviewed verified by ORBi |
Tchéoubi, E. S. R., Akpovi, C. D., Coppée, F., Tassin, A., Decleves, A.-E., Fiogbé, S. E., Sègbo, G. J., Laurent, S., & Burtea, C. (11 September 2022). PCSK9 variants affect differently the risk of type 2 diabetes mellitus development. Potential impact on the therapy with PCSK9 inhibitors [Poster presentation]. 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis. Peer reviewed |
 | LIMPENS, M., Derenne, A., Burtea, C., Legrand, A., Decleves, A.-E., Coppée, F., & Tassin, A. (17 June 2022). Towards a muscle-targeted delivery of antisense agents against DUX4 [Poster presentation]. The 29th FSHD Society's annual International Research Congress 2022. Editorial reviewed |
 | Decarnoncle, M., Decroo, C., Coppée, F., Tassin, A., Tagliatti, V., Villers, A., Colet, J.-M., Nonclercq, D., Legrand, A., Ris, L., Wattiez, R., & Decleves, A.-E. (25 November 2021). Développement d'une trousse de dosage d'organokines par spectrométrie de masse [Poster presentation]. Networking EpiCURA-UMONS, Baudour, Belgium. |
 | Pierre, L., Decarnoncle, M., Marlier, H., Coppée, F., Juszczak, F., & Decleves, A.-E. (25 November 2021). Plateforme Rein-Santé : Focus sur la cellule tubulaire proximale [Poster presentation]. Networking EpiCURA-UMONS, Baudour, Belgium. |
 | TCHEOUBI, S. E. R.* , AKPOVI, C. D., Coppée, F., Decleves, A.-E., FIOGBE, S. E., Sègbo, G. J., AGBANGLA, C., Laurent, S., & Burtea, C. (06 September 2021). PCSK9 intronic variant rs142149050 is associated with low level of LDL-cholesterol and lower cardiovascular risk in type 2 diabetes [Paper presentation]. - 4ème Congrès international de la Société Africaine de Physiologie et Physiopathologie (SA2P), Cotonou, Benin. Peer reviewed |
Tchéoubi, E. R. S., AKPOVI, C. D., Coppée, F., Decleves, A.-E., Sègbo, G. J., AGBANGLA, C., Laurent, S., & Burtea, C. (24 July 2020). A novel cholesterol-lowering PCSK9 variant is associated with low blood glucose level and lower cardiovascular risk in type 2 diabetes [Paper presentation]. 4th Global Summit on Diabetes and Endocrinology, Scientific Federation-Diabetes, Manchester, Unknown/unspecified. |
 | Coppée, F., Lechien, J., Decleves, A.-E., Tafforeau, L., & Saussez, S. (01 July 2020). Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations. New Microbes and New Infections, 36, 100696. doi:10.1016/j.nmni.2020.100696 Peer Reviewed verified by ORBi |
Claus, C., Salvin, M., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (25 June 2020). Determination of the major DUX4/4c partner: the multifunctional C1qBP protein [Poster presentation]. FSHD Society International Research Congress, Washington , United States - District of Columbia. |
 | Derenne, A., Tassin, A., Nguyen, T. H., DeRoeck, E., Jenart, V., Ansseau, E., Belayew, A., Coppée, F., Decleves, A.-E., & Legrand, A. (2020). Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics. Scientific Reports. Peer reviewed |
 | Lechien, J., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., Chekkoury-Idrissi, Y., Hans, S., Lopez-Delgado, I., Calvo-Henriquez, C., Lavigne, P., Falanga, C., Barillari, M. R., Cammaroto, G., Khalife, M., ... Saussez, S. (04 June 2020). Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino-Laryngology, Apr 6, 1-11. doi:10.1007/s00405-020-05965-1 Peer Reviewed verified by ORBi |
Dudome, V., Genva, S., Coppée, F., & Decleves, A.-E. (31 January 2020). Mitochondrial dysfunction and oxidative stress response induced by palmitate in human muscle cells [Paper presentation]. 14 th meeting of the FRS-FNRS Contact Group on Oxidative Processes and Antioxidants, Mons, Belgium. |
Dudome, V., Coppée, F., & Declèves, A.-E. (31 January 2020). Mitochondrial dysfunction and oxidative stress response induced by palmitate in human muscle cells [Paper presentation]. 14th meeting of the FRS-FNRS Contact group on Oxidative Proceses and Antioxidants, UMONS, Belgium. |
Claus, C., Salvin, M., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (31 January 2020). Does the multifunctional protein C1qBP play a role in oxidative stress triggering in FSHD skeletal muscle cells? [Poster presentation]. Oxidative stress, redox regulation and cell fate, The FNRS contact Group: Oxidative Processes and Antioxidants, Umons, Mons, Belgium. |
Claus, C., Salvin, M., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (30 January 2020). Does the multifunctional protein C1qBP play a role in the susceptibility of oxidative stress in the muscle dystrophy FSHD? [Poster presentation]. Oxidative stress, redox regulation and cell fate, Mons, Belgium. |
Coppée, F. (2019). FSHD: d'un projet de thèse(s) à la rédaction d'un projet Européen (EJP-RD 2019). |
 | TCHEOUBI, S. E. R., AKPOVI, C. D., Coppée, F., Decleves, A.-E., Laurent, S., AGBANGLA, C., & Burtea, C. (16 September 2019). PCSK9 synonymous variant gln342=, insulin and adiponectin levels in type 2 diabetes mellitus patients [Paper presentation]. VIIème Colloques des sciences, cultures et technologies, Campus universitaire d'Abomey-Calavi, Benin. |
Claus, C., Tomaiuolo, S., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (08 July 2019). Direct interaction of DUX4/4c with the multifunctional protein C1QBP in the FSHD pathology [Poster presentation]. Advances in skeletal muscle biology in health and disease, Gainesville, United States. |
Claus, C., & Coppée, F. (2019). FSH-Time 'Où en est la recherche ? '. |
Claus, C., Tomaiuolo, S., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (21 June 2019). Direct interaction of DUX4/4c with the multifunctional protein C1QBP in the FSHD pathology [Poster presentation]. Discovery Worflow Toolsfo Small Molecules and Biologics-Promega, Bruxelles, Belgium. |
TCHEOUBI, S. E. R., AKPOVI, C. D., Coppée, F., Decleves, A.-E., Laurent, S., & Burtea, C. (21 June 2019). Linking PCSK9 genetic variants with insulin impairment in type 2 diabetes mellitus patients [Paper presentation]. 2ème Journées Africaines d'Endocrinologie clinique, Abidjan, Côte d’Ivoire. |
TCHEOUBI, S. E. R., Akpovi, C., Coppée, F., Decleves, A.-E., & Laurent, S. (05 June 2019). Linking PCSK9 genetic variants with insulin impairment in type 2 diabetes mellitus patients [Poster presentation]. Congrès sur l'endocrinologie, Abidjan, Côte d’Ivoire. |
 | Claus, C., Dudome, V., Derenne, A., Coppée, F., & Decleves, A.-E. (2019). Draw my phD. |
 | Wauters, M., Vertraelen, P., Garcia-Diaz Barriga, G., Leroy, B., Delporte, C., Coppée, F., Van Antwerpen, P., Wattiez, R., De Vos, W., & Ris, L. (24 May 2019). Toxicity assessment of the hyperphosphorylated Tau protein on the neuronal network connectivity [Paper presentation]. 13th National Congress of the Belgian Society for Neuroscience, Brussels, Belgium. |
Claus, C., Tomaiuolo, S., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (17 May 2019). Direct interaction of DUX4/4c with the multifunctional protein C1QBP in the FSHD pathology [Poster presentation]. Ecole doctorale EDT-BCMB (Biologie Cellulaire et Moléculaire & Biochimie - FNRS), Bruxelles, ULB - Campus Erasme, Belgium. |
 | TCHEOUBI, S. E. R., Coppée, F., Decleves, A.-E., Laurent, S., AKPOVI, C. D., & Burtea, C. (17 May 2019). PCSK9 gene variants in west - African type 2 diabetes mellitus (T2DM) patients [Poster presentation]. Ecole doctorale EDT-BCMB (Biologie Cellulaire et Moléculaire & Biochimie - FNRS), Bruxelles, ULB - Campus Erasme, Belgium. |
Claus, C., Tomaiuolo, S., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (03 May 2019). Direct interaction of DUX4/4c with the multifunctional protein C1QBP in the FSHD pathology [Poster presentation]. Mardi de la Recherche - UMONS - FWEG, Mons, Belgium. |
 | Dudome, V., Coppée, F., Decleves, A.-E., & Dabauvalle, M. C. (29 April 2019). Lipotoxicity and oxidative stress induced by palmitate in human muscle cells [Poster presentation]. 26th European Congress on Obesity, Glasgow, Unknown/unspecified. |
Nguyen, T. H., Derenne, A., Ansseau, E., De Roeck, E., Coppée, F., Decleves, A.-E., Tassin, A., & Legrand, A. (27 March 2019). Development of easy outcome measures for the in vivo screening of therapeutical agents targeting DUX4 in FSHD [Poster presentation]. MYOLOGY, Bordeaux, France. Editorial reviewed |
 | Derenne, A., Kouakou, C., Belayew, A., Decleves, A.-E., Tassin, A., Burtea, C., & Coppée, F. (08 March 2019). Development of peptides for specific skeletal muscle targeted drug delivery [Poster presentation]. 2019 Advances in Skeletal Muscle Biology in Health and Disease, University of Florida, United States - Florida. Editorial reviewed |
Dudome, V., Coppée, F., Decleves, A.-E., & Dabauvalle, M. C. (13 January 2019). Lipotoxicity and oxidative stress induced by palmitate in human muscle cells' [Poster presentation]. Ecole doctorale EDT-BCMB (Biologie Cellulaire et Moléculaire & Biochimie - FNRS), Bruxelles, ULB - Campus Erasme, Belgium. |
Dudome, V., Coppée, F., & Decleves, A.-E. (31 October 2018). Lipotoxicity and oxidative stress induced by palmitate in human muscle cells [Poster presentation]. 7th European worshop on lipid mediators, Bruxelles, Belgium. |
  | Claus, C., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (20 September 2018). Direct interaction of DUX4/4c with the multifunctional protein C1QBP in the pathology FSHD [Poster presentation]. Structural Dynamics In Cellular Communication, Bruxelles, Belgium. |
 | Wauters, M., Leroy, B., Coppée, F., & Ris, L. (13 August 2018). Internalisation and toxic effects resulting from the addition of extracellular hyperphosphorylated monomeric Tau [Paper presentation]. Belgian Brain Congress 2018-Belgian Brain Council, Liège, Belgium. |
Wauters, M., Coppée, F., & Ris, L. (10 July 2018). A role for hyperphosphorylated monomeric Tau in the propagation of Tau pathology [Paper presentation]. 11th FENS Forum of Neuroscience, Berlin, Germany. |
 | Claus, C., Salvin, M., Tayri, T., Ansseau, E., Decleves, A.-E., Wilton, S., Kalisman, N., & Coppée, F. (08 June 2018). Direct interaction of DUX4/4c with the multifunctional protein C1QBP [Poster presentation]. FSH International Research Congress, Las Vegas, United States - Nevada. |
Dudome, V., Coppée, F., & Declèves, A.-E. (18 February 2018). Lipotoxicity and oxidative stress induced by palmitate in human muscle cells [Poster presentation]. Scientific Meeting FNRS Contact Group 'Oxidative Processes and Antioxidants', Namur, Belgium. |
 | Vanderplanck, C., Tassin, A., Ansseau, E., Charron, S., Wauters, A., Lancelot, C., Vancutsem, K., Laoudj Chevinesse, D., Belayew, A., & Coppée, F. (12 January 2018). 'Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei'. Skeletal Muscle, 8 (2). doi:10.1186/s13395-017-0148-4 Peer reviewed |
 | Ansseau, E., Sciot, M., Goudji, C., Castella, S., Larcher, J.-C., Belayew, A., & Coppée, F. (2017). FSHD and OPMD: Deregulation of IGF2BP1-mRNP components during the differentiation of FSHD muscle cells [Paper presentation]. 22nd International Congress of the Word Muscle Society, Saint Malo, France. |
Derenne, A., Tassin, A., Burtea, C., Decleves, A.-E., & Coppée, F. (13 September 2017). Development of specific molecules using the phage display technology allowing a targeted drug delivery to skeletal muscles in the aim to treat muscular disorders.» [Paper presentation]. Journée PhD day EDT en Sciences Pharmaceutiques, Liège, Belgium. Editorial reviewed |
 | Derenne, A., De Roeck, E., Tassin, A., Coppée, F., Decleves, A.-E., & Legrand, A. (11 May 2017). DUX4 surexpression and silencing in a murine model [Poster presentation]. Interuniversity PhD student, Liège, Belgium. |
Derenne, A., De Roeck, E., Tassin, A., Coppée, F., Belayew, A., Decleves, A.-E., & Legrand, A. (07 March 2017). DUX4 surexpression and silencing in a murine model [Poster presentation]. Mardi des Chercheurs (MdC2017), Mons, Belgium. |
 | Ansseau, E., Vanderplanck, C., Wauters, A., Harper, S. Q., Coppée, F., & Belayew, A. (03 March 2017). Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes, 8 (3), 93. doi:10.3390/genes8030093 Peer Reviewed verified by ORBi |
 | Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (16 November 2016). Study of atrophy in Facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. Bioforum, Liège Ulg , Unknown/unspecified. |
 | Ansseau, E., Lancelot, C., Wauters, A., Vanderplanck, C., Belayew, A., & Coppée, F. (10 November 2016). Transcription factors DUX4 and DUX4c associate with mRNP granules in the cytoplasm of fusing myoblasts: a new function in translation regulation? [Poster presentation]. FSH Society, Boston, United States - Massachusetts. |
 | Ansseau, E., Lancelot, C., Belayew, A., & Coppée, F. (04 October 2016). Transcription factors DUX4 and DUX4c associate with mRNP granules in the cytoplasm of fusing myoblasts: a new function in translation regulation? [Poster presentation]. 21st International WMS Congress, Granada, Spain. |
P, D., Kiseleva, E., Kharchenko, O., Ivashkin, E., Pichugin, A., Dessen, P., Robert, T., Coppée, F., Belayew, A., Camac, G., Laoudj Chevinesse, D., Lipinski, M., Vasiliev, A., & Vassetzky, Y. (04 October 2016). Dux4 controls migration of mesenchymal stem cells through the Cxcr4-Sdf1 axis. Oncotarget, 7 (40), 65090-65108. doi:10.18632/oncotarget.11368 Peer reviewed |
Coppée, F. (17 June 2016). New Insights in FSHD [Paper presentation]. Algemeen Ziekenhuis Sint-Jan, Bruges, Belgium. |
 | Ansseau, E., O, J., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj Chevinesse, D., Wattiez, R., Harper, S., Belayew, A., & Coppée, F. (14 March 2016). The translocation of DUX4 and DUX4c during myoblast differentiation allows their association with nucleo-cytoplasmic proteins associated with mRNP granules [Poster presentation]. International Congress Of Myology, Lyon, France. |
De La Kethulle De Ryove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton, S., Coppée, F., Lagneaux, L., & Belayew, A. (14 March 2016). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow [Poster presentation]. 5th International Congress of Myology, Lyon, France. |
 | Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (14 March 2016). 'Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy.' [Poster presentation]. 5th International Congress of Myology, Lyon, France. |
Ansseau, E., Eidal, J., Lancelot, C., Tassin, A., Matteotti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (2016). Homologous transcription factors DUX4 and DUX4c associate with cytoplasmic proteins during muscle differentiation. PLoS ONE. Peer reviewed |
Ansseau, E., & Coppée, F. (18 January 2016). « Homologous DUX transcription factors interact with cytoplasmic proteins during muscle differentiation [Paper presentation]. Séminaires de l'institut de Myologie, Paris, France. |
Ansseau, E., Eidahl, J. O., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (06 October 2015). The translocation of DUX4 and DUX4c during myoblast differentiation allows their association with nucleo-cytoplasmic proteins associated with mRNP granules [Paper presentation]. FSH society, Boston, United States - Massachusetts. |
De La Kethulle De Ryhove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton D., S., Coppée, F., Lagneaux, L., & Belayew, A. (06 October 2015). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow [Paper presentation]. FSH Society, Boston, United States - Massachusetts. |
Ansseau, E., Eidahl, J. O., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (04 October 2015). Unexpected location of DUX4/4c transcription factors in the cytoplasm suggests a role in mRNP granules and translation regulation [Poster presentation]. International World Muscle Society Congress, Brighton, United Kingdom. |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Paper presentation]. International World Muscle Society congress, Brighton, United Kingdom. |
 | Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (23 September 2015). Study of atrophy in Facioscapulohumeralmuscular dystrophy (FSHD) [Poster presentation]. EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease, Ascona , Unknown/unspecified. |
Lancelot, C., Mascolo, C., Nonclercq, D., Carnac, G., Laoudj-Chenivesse, D., Coppée, F., & Belayew, A. (22 September 2015). How does fibrosis in FSHD muscle contribute to the lack of muscle regeneration ? [Poster presentation]. EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease, Ascona , Unknown/unspecified. |
De La Kethulle De Ryhove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton D., S., Coppée, F., Lagneaux, L., & Belayew, A. (20 July 2015). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow. Stem Cells and Development, 24 (22), 2674-86. doi:10.1089/scd.2014.0575 Peer Reviewed verified by ORBi |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (22 May 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Poster presentation]. Journée UMHAP from lab to bedside, Mons, Belgium. |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (17 April 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of facioscapulohumeral muscular dystrophy (FSHD [Poster presentation]. Novel Therapies for monogennic diseases, Paris, France. |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (15 April 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Poster presentation]. symposium de thérapie génique du Collège de France, Paris, France. |
Coppée, F. (04 April 2015). La double vie de DUX4 et DUX4c [Paper presentation]. AMIS FSH - Rencontre de printemps, Mons, Belgium. |
 | Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (10 March 2015). Study of atrophy in Facioscapulohumeralmuscular dystrophy (FSHD) [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (10 March 2015). Membrane proteins : putative FSHD biomarkers [Poster presentation]. 8ème édition de la Matinée de Chercheurs, Mons, Belgium. |
De La Kethulle De Ryhove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton D., S., Coppée, F., Lagneaux, L., & Belayew, A. (11 February 2015). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow [Poster presentation]. Télévie's Research Seminar, ULB-Erasme, Belgium. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (19 October 2014). Membrane proteins: putative FSHD biomarkers? [Poster presentation]. FSH Society international research consortium and research planning meeting, San Diego, United States - California. |
 | Ansseau, E., Matteoti, C., Tassin, A., Lancelot, C., Leroy, B., Hubeau, C., Nachtegael, C., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Meyer, P., Carnac, G., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (17 October 2014). Unexpected role for DUX transcription factors into the cytoplasm [Paper presentation]. International Research Consortium & Research Planning Meetings, San Diego, United States - California. |
 | Charron, S., Vancutsem, K., Vanderplanck, C., Lancelot, C., Carnac, G., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (17 October 2014). WNT pathway alterations in FSHD [Poster presentation]. FSH Society international research consortium and research planning meeting, San Diego, United States - California. |
Derenne, A., Tassin, A., Conotte, S., Coppée, F., Belayew, A., & Legrand, A. (17 October 2014). Comparison of two methods of naked DNA delivery in mice: which one is the most appropriate in the FSHD context? [Poster presentation]. FSH Society international research consortium and research planning meeting, San Diego, United States - California. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Coppée, F., Wattiez, R., & Belayew, A. (08 July 2014). Membrane proteins : putative FSHD biomarkers? [Poster presentation]. ICNMD 13th International Congress in NeuroMuscular Diseases, Nice, France. |
Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (08 July 2014). Study of atrophy in Facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. ICNMD 13th International Congress in NeuroMuscular Diseases, Nice, France. |
Lancelot, C., Ansseau, E., Tassin, A., Matteoti, C., Leroy, B., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (06 July 2014). Study of the double homeodomain DUX protein partners: focus on the interaction with desmin [Paper presentation]. IF-NMD Workshop Nice 2014 - Satellite Workshop to ICNMD, Nice, France. |
Tassin, A., Ansseau, E., Matteotti, C., Lancelot, C., Leroy, B., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (14 May 2014). Study of the double homeodomain DUX protein partners highlights DUX4c involvement in human muscle regeneration [Paper presentation]. EMBO Conference : Molecular Biology of Muscle Development and Regeneration, Acaya-Lecce, Italy. Editorial reviewed |
Charron, S., Vancutsem, K., Vanderplanck, C., Lancelot, C., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (14 May 2014). WNT pathway alterations in FSHD [Poster presentation]. EMBO Conference : Molecular Biology of Muscle Development and Regeneration, Acaya-Lecce, Italy. |
De La Kethulle De Ryhove, L., Ansseau, E., Geens, M., Coppée, F., Sermon, K., Lagneaux, L., & Belayew, A. (2014). DUX4 expression during Osteogenic Differentiation in MSCs [Paper presentation]. 20th ISCT Annual Meeting (International Society Cellular Therapy) 2014, Palais des Congrès, Paris, France. |
De La Kethulle De Ryhove, L., Ansseau, E., Geens, M., Coppée, F., Sermon, K., Lagneaux, L., & Belayew, A. (25 April 2014). DUX4 expression during Osteogenic Differentiation in MSCs [Poster presentation]. 20th ISCT Annual Meeting (International Society Cellular Therapy) 2014, Palais des Congrès, Paris, France. |
De La Kethulle De Ryhove, L., Ansseau, E., Geens, M., Coppée, F., Sermon, K., Lagneaux, L., & Belayew, A. (05 December 2013). DUX4 expression during Osteogenic Differentiation in MSCs [Poster presentation]. Journée des jeunes chercheurs Télévie, Université Catholique de Louvain, Belgium. |
| Lancelot, C., Carnac, G., Nonclercq, D., Delrée, P., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (28 November 2013). Development of fibrosis and its impact on muscle regeneration in FSHD muscle [Poster presentation]. 11ème Journées de la Société Française de Myologie, Montpellier, France. |
| Vanderplanck, C., Tassin, A., Lancelot, C., Ansseau, E., Nonclercq, D., Delrée, P., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (27 November 2013). DUX4c, a DUX4-homologue, causes the FSHD disorganized myotube phenotype: an additional target for therapeutic strategies [Paper presentation]. Colloque Myogenèse XVI, Montpellier, France. |
Ansseau, E., Charron, S., Laoudj-Chenivesse, D., Coppée, F., & Belayew, A. (21 October 2013). Interplay between Sp1, YY1 and MYOD in transcription regulation of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD) [Paper presentation]. FSH Society (FacioScapuloHumeral Muscular Dystrophy) International Reasearch Consortium & Reasearch Planning Meeting, Boston, United States - Massachusetts. |
De La Kethulle De Ryhove, L., Ansseau, E., Coppée, F., & Belayew, A. (06 June 2013). DUX4 expression in embryonic stem cells [Poster presentation]. 3rd Heidelberg forum for young life scientists, DFKZ, Heidelberg, Germany. |
| Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (24 May 2013). Evaluation of new antisense oligomers targeting the DUX4 mRNA [Poster presentation]. Journée de l'Institut de recherche en sciences et technologies de la santé, Mons, Belgium. |
 | Tassin, A., Vanderplanck, C., Ansseau, E., Derenne, A., Coppée, F., & Belayew, A. (24 May 2013). Different approaches to evaluate antisense strategies against the causal gene of the FSHD myopathy [Poster presentation]. Journée de l'Institut de recherche en sciences et technologies de la santé, Mons, Belgium. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (24 May 2013). Caveolar proteins: putative FSHD biomarkers? [Poster presentation]. 1st Health Institute Day, Mons, Belgium. |
Lancelot, C., Carnac, G., Nonclercq, D., Delrée, P., Coppée, F., & Belayew, A. (23 May 2013). Development of fibrosis and its impact on muscle regeneration in FSHD muscle [Poster presentation]. Journée de l'institut santé, Mons, Belgium. |
Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (22 April 2013). Evaluation of new antisense oligomers targeting the DUX4 mRNA as a therapeutic strategy for FSHD [Paper presentation]. MDA Scientific Conference, Washington DC, United States - District of Columbia. |
De La Kethulle De Ryhove, L., Ansseau, E., Coppée, F., & Belayew, A. (12 March 2013). Study of DUX4 expression and function in non-muscular cells [Poster presentation]. 7ème édition de la Matinée de Chercheurs, Mons, Belgium. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (29 January 2013). Caveolar proteins: putative FSHD biomarkers? [Poster presentation]. ', Journée de l'école doctorale en sciences biomédicales et pharmaceutiques, UMONS, Mons, Belgium. |
 | Tassin, A., Laoudj-Chenivesse, D., Vanderplanck, C., Barro, M., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (01 January 2013). DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? Journal of Cellular Molecular Medecine, 17 (1), 1-15. doi:10.1111/j.1582-4934.2012.01647.x Peer reviewed |
 | Tassin, A., Leroy, B., Laoudj-Chenivesse, D., Wauters, A., Vanderplanck, C., Le Bihan, M.-C., Coppée, F., Wattiez, R., & Belayew, A. (18 December 2012). FSHD Myotubes with Different Phenotypes Exhibit Distinct Proteomes. PLoS ONE, 7 (12), 51865. doi:10.1371/journal.pone.0051865 Peer reviewed |
De La Kethulle De Ryhove, L., Dimitrova, J., Ansseau, E., Geens, M., Lagneaux, L., Sermon, K., Coppée, F., & Belayew, A. (10 December 2012). DUX4 expression in non-muscle cells [Poster presentation]. Télévie 2013, Liège, Belgium. |
 | Tassin, A., Vanderplanck, C., Leroy, B., Charron, S., Ansseau, E., Wauters, A., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (07 November 2012). Investigations on the FSHD disorganized myotube phenotype [Poster presentation]. FSH Society International Reasearch Consortium Meeting, San Francisco, United States. |
Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (06 November 2012). Evaluation of new antisense oligomers targeting the DUX4 mRNA as a therapeutic strategy for FSHD [Paper presentation]. FSH Society International Reasearch Consortium Meeting, San Francisco, United States. |
Charron, S., Vanderplanck, C., Vancutsem, K., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (25 September 2012). Facioscapulohumeral dystrophy: focus on the WNT perturbation [Poster presentation]. EMBO Meeting, Nice, France. |
Charron, S., Belayew, A., & Coppée, F. (29 November 2011). WNT et FOXO dans la FSHD [Paper presentation]. Merci Téléthon, Forchie-la-marche, Belgium. |
 | Richards, M., Coppée, F., Thomas, N., Belayew, A., & Upadhyaya, M. (2011). Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Human Genetics. doi:10.1007/s00439-011-1100-z |
| Ansseau, E., Mattéotti, C., Gerbaux, C., Yip, C., Pire, E., Vachaudez, V., Cloet, S., Wattiez, R., Coppée, F., & Belayew, A. (07 November 2011). DUX4 and DUX4c protein partners in muscle cells [Poster presentation]. FSH Society (FSHD) 2011 International Research Consortium and Researchplanning meetings, Boston, United States - Massachusetts. |
| Charron, S., Vanderplanck, C., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (07 November 2011). Perturbation of the WNT signaling pathway in FSHD [Paper presentation]. FSH Society (FSHD) 2011 International Research Consortium and Researchplanning meetings, Boston, United States - Massachusetts. |
| Tassin, A., Laoudj-Chenivesse, D., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (07 November 2011). Detection of endogenous DUX4 protein in FSHD muscles: could the spreading of a rare protein cause FSHD? [Poster presentation]. FSH Society International Research Consortium & Reasearch Planning Meeting, Boston, United States - Massachusetts. |
 | Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (01 November 2011). The FSHD atrophic myotube phenotype is caused by DUX4 expression and corrected by its suppression. PLoS ONE, 6 (10), 26820. doi:10.1371/journal.pone.0026820 Peer reviewed |
Charron, S., Belayew, A., & Coppée, F. (29 October 2011). La signalisation cellulaire WNT et FOXO [Paper presentation]. Assemblée générale de l'association Amis FSH Europe, Agde, France. |
 | Dmitriev, P., Petrov, A., Ansseau, E., Stankevicins, L., Charron, S., Kim, E., Bos, T., Robert, T., Turki, A., Coppée, F., Belayew, A., Lazar, V., Carnac, G., Laoudj-Chenivesse, D., Lipinski, M., & Vassetzky, Y. (21 September 2011). The Kruppel-like Factor 15 as a Molecular Link between Myogenic Factors and a Chromosome 4q Transcriptional Enhancer Implicated in Facioscapulohumeral Dystrophy. Journal of Biological Chemistry, 286, 44620-44631. Peer Reviewed verified by ORBi |
Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (12 May 2011). Interfering with the transcription deregulation cascades in fshd [Paper presentation]. 4th international congress of myology 2011, Lille , France. |
| Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Vanderplanck, C., Wauters, A., Turky, D., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (12 May 2011). The galectin-1 gene is activated in FSHD Myotubes as a result of the DUX4 transcriptional deregulation cascade [Poster presentation]. 4th international congress of myology 2011, Lille , France. |
 | Ansseau, E., Charron, S., Guiguen, A., Van Lint, C., Coppée, F., & Belayew, A. (12 May 2011). YY1 and MyoD are transcriptional activator and inhibitor, respectively, of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. 4th international congress of myology 2011, Lille , France. |
Vanderplanck, C., Ansseau, E., Charron, S., Tassin, A., Turki, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (06 May 2011). SUPPRESSION OF DUX4 OR DUX4C EXPRESSION BY ANTISENSE STRATEGIES IN A THERAPEUTIC APPROACH FOR FSHD [Paper presentation]. 7th AGTS Meeting, Melbourne, Australia. |
Ansseau, E., Charron, S., Guiguen, A., Van Lint, C., Coppée, F., & Belayew, A. (22 March 2011). YY1 and MyoD are transcriptional activator and inhibitor, respectively, of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. La matinée des chercheurs, Mons, Unknown/unspecified. |
Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (14 March 2011). Suppression of DUX4 or DUX4c protein expression by antisense strategies in a therapeutic approach for FSHD [Paper presentation]. MDA national scientific conference Neuromuscular Therapeutic Strategies: Overcoming the Barriers from Microscope to Marketplace, Las Vegas, United States - Nevada. |
Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (25 November 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry [Poster presentation]. VIIIè journées annuelles Société Française de Myologie, Nice, France. |
Wallace, L. M., Garwick, S. E., Mei, W., Belayew, A., Coppée, F., Ladner, K., Guttridge, D., Yang, J., & Harper, S. Q. (02 November 2010). DUX4 over-expression recapitulates FSHD-associated phenotypes in vivo [Paper presentation]. American Society of Human Genetics, 2010 Annual Meeting, Washington DC, United States - District of Columbia. |
 | Wallace, L. M., Garwick, S. E., Mei, W., Belayew, A., Coppée, F., Ladner, K. J., Guttridge, D., Yang, J., & Harper, S. Q. (2010). DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Annals of Neurology. doi:10.1002/ana.22275 Peer Reviewed verified by ORBi |
Tassin, A., Leroy, B., Ansseau, E., Pire, E., Charron, S., Coppée, F., Wattiez, R., & Belayew, A. (25 October 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry [Poster presentation]. FSHD International Research Consortium Meeting, Boston, United States - Massachusetts. |
Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (21 October 2010). Suppression of DUX4 or DUX4c protein expression by antisense strategies as a therapeutic approach for FSHD [Paper presentation]. FSH Society International Research Consortium & Research Planning Meeting, Boston, United States - Massachusetts. |
Vanderplanck, C., Ansseau, E., Coppée, F., Belayew, A., & Wilton D., S. (01 September 2010). Agents useful in treating Facioscapulohumeral muscular dystrophy. |
Tassin, A., Coppée, F., Leroy, B., Sauvage, S., Preillon, J., Erculisse, V., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (09 November 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures [Paper presentation]. FSH Society International Research Consortium and Research Planning Meetings, Boston, United States - Massachusetts. Editorial reviewed |
Dmitriev, P., Petrov, A., Ansseau, E., Charron, S., Coppée, F., Belayew, A., Carnac, G., Turki, A., Laoudj-Chenivesse, D., Lipinski, M., & Vassetzky, Y. (06 November 2009). Kruppel-like factor KLF15 interacts with the D4Z4 enhancer and upregulates a FSHD-related gene DUX4c [Poster presentation]. FSH Society International Research Consortium and Research Planning Meetings, Boston, United States - Massachusetts. |
 | Tassin, A., Charron, S., Vanderplanck, C., Coppée, F., & Belayew, A. (2009). Des techniques en 'omique' pour comprendre une maladie héréditaire des muscles. |
Charron, S., Vanderplanck, C., Belayew, A., & Coppée, F. (17 October 2009). WNT and FOXO signaling pathways in FSHD [Poster presentation]. Protein modifications in development and diseases, Liège, Belgium. |
 | Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Tassin, A., Vanderplanck, C., Sauvage, S., Barro, M., Mahieu, I., Leroy, A., Leclercq, I., Mainfroid, V., Figlewicz, D., Mouly, V., Butler-Browne, G., Belayew, A., & Coppée, F. (01 October 2009). DUX4c Is Up-Regulated in FSHD. It Induces the MYF5 Protein and Human Myoblast Proliferation. PLoS ONE, 4 (10), 7482. doi:10.1371/journal.pone.0007482 Peer reviewed |
 | Capouillez, A., Debauve, G., Decaestecker, C., Filleul, O., Chevalier, D., Mortuaire, G., Coppée, F., Leroy, X., Belayew, A., & Saussez, S. (01 September 2009). The Helicase-Like Transcription Factor is a strong predictor of recurrence in Hypopharyngeal but not in Laryngeal squamous cell carcinomas. Histopathology, 55, 77-90. Peer Reviewed verified by ORBi |
Tassin, A., Coppée, F., Leroy, B., Erculisse, V., Sauvage, S., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (27 July 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures [Paper presentation]. International Symposium Signal transduction and disease, Aachen, Germany. Editorial reviewed |
 | Dumonceaux, J., Marie, S., Ferry, A., Coppée, F., Belayew, A., Voit, T., & Butler-Browne, G. (2009). Dux4 over-expression in normal mouse: Generation of a mouse model with an FSHD phenotype? [Paper presentation]. 14th International WMS Congress, Genève, Switzerland. |
 | Aouay, A., Coppée, F., Cloet, S., Cuvelier, P., Belayew, A., Lagneau, P.-E., & Mullender, C. (01 November 2008). Molecular characterization of Prototheca strains isolated from bovine mastitis. Journal de Mycologie Médicale, 18, 224-227. doi:10.1016/j.mycmed.2008.10.002 Peer reviewed |
 | Bosnakovski, D., Xu, Z., Gang, E. J., Galindo, C. L., Liu, M., Simsek, T., Garner, H. R., Agha-Mohammadi, S., Tassin, A., Coppée, F., Belayew, A., Perlingeiro, R., & Kyba, M. (01 October 2008). An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO Journal, 27 (20), 2766-79. Peer Reviewed verified by ORBi |
Tassin, A., Vanderplanck, C., Ansseau, E., Marcowyzc, A., Barro, M., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (26 May 2008). Studies on the expression and function of DUX4c, a gene located close to the FSHD locus [Poster presentation]. 3ème Congrès International de Myologie, Marseille, France. |
Tassin, A., Ansseau, E., Vanderplanck, C., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Chen, Y.-W., Belayew, A., & Coppée, F. (21 January 2008). DUX4 and DUX4c activate different pathways in Facioscapulohumeral dystrophy [Paper presentation]. Colloque « Myogenese IX », Institut de Myologie, Paris, France. Editorial reviewed |
 | Capouillez, A., Decaestecker, C., Filleul, O., Chevalier, D., Coppée, F., Leroy, X., Belayew, A., & Saussez, S. (01 January 2008). Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas. Virchows Archiv, 453 (5), 491-499. Peer Reviewed verified by ORBi |
 | Tassin, A., Vanderplanck, C., Ansseau, E., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Dabauvalle, M. C., Wehnert, M., Chen, Y.-W., Belayew, A., & Coppée, F. (2008). Study of DUX4 and DUX4c in facioscapulohumeral muscular dystrophy [Paper presentation]. 13th International WMS Congress, Newcastle upon Tyne, United Kingdom. |
Ansseau, E., Tassin, A., Vanderplanck, C., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Chen, Y.-W., Belayew, A., & Coppée, F. (04 November 2007). Further studies on the DUX4, DUX4c and PITX1 genes in FSHD [Paper presentation]. FSHD international Workshop meeting, San Diego, United States - California. |
 | Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Mattéotti, C., van Acker, A., Leo, O., Figlewicz, D., Barro, M., Laoudj-Chenivesse, D., Belayew, A., Coppée, F., & Chen, Y.-W. (01 November 2007). DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proceedings of the National Academy of Sciences of the United States of America, 104 (46), 18157-18162. doi:10.1073/pnas.0708659104 Peer Reviewed verified by ORBi |
 | Kowaljow, V., Marcowycz, A., Ansseau, E., Conde, C. B., Sauvage, S., Mattéotti, C., Arias, C., Corona, E. D., Nuñez, N. G., Leo, O., Wattiez, R., Figlewicz, D., Laoudj-Chenivesse, D., Belayew, A., Coppée, F., & Rosa, A. L. (01 June 2007). The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscular Disorders, 17 (8), 611-23. doi:10.1016/j.nmd.2007.04.002 Peer Reviewed verified by ORBi |
Tassin, A., Ansseau, E., Sauvage, S., Mattéotti, C., Van Acker, A.-M., Figlewicz, D., Laoudj-Chenivesse, D., Oberdan, L., Coppée, F., & Belayew, A. (18 December 2006). Evidence for the expression of the DUX4 gene in primary myoblasts of patients affected with Facioscapulohumeral muscular dystrophy [Poster presentation]. 194th Congrès de la Société Belge de Biochimie et de Biologie Moléculaire / 'Young Scientists Day, Gembloux, Belgium. |
 | Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Sauvage, S., Barro, M., Tassin, A., Mattéotti, C., van Acker, A., Leroy, A., Leclercq, I., Leo, O., Figlewicz, D., Belayew, A., & Coppée, F. (2006). Characterization of the DUX4c gene located within a repeated element close to the FSHD locus [Paper presentation]. 11th International Congress of the World Muscle Society, Bruges, Belgium. |
Ansseau, E., Tassin, A., Sauvage, S., Laoudj-Chenivesse, D., Barro, M., Figlewicz, D., Coppée, F., & Belayew, A. (09 October 2006). DUX4 gene expression in FSHD primary myoblasts [Paper presentation]. FSHD International Consortium Research Meeting, New Orleans, United States - Louisiana. |
Ansseau, E., Coppée, F., & Belayew, A. (20 May 2006). Fonctional characterization of the DUX4 et DUX4c genes located within repeated elements at the FSHD locus [Poster presentation]. Bioforum, Liège, Belgium. |
Marcowycz, A., Mahieu, I., Tassin, A., Coppée, F., & Belayew, A. (17 May 2006). The DUX4 and DUX4c proteins, encoded by candidate genes for a muscular dystrophy (FSHD), have opposite functions in vivo [Poster presentation]. Bioforum, Liège, Belgium. |
 | Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Barro, M., Sauvage, S., Mattéotti, C., Mahieu, I., Tassin, A., Van Acker, A.-M., Leo, O., Fliglewicz, D., Coppée, F., & Belayew, A. (13 January 2006). Etude de DUX4 et DUX4c, gènes candidats pour la FSHD [Paper presentation]. Club muscle 'V', Paris, France. |
 | Laumonier, C., Segers, J., Laurent, S., Michel, A., Coppée, F., Belayew, A., Vander Elst, L., & Muller, R. (01 January 2006). A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. Journal of Biomolecular Screening, 11 (5), 537-545. doi:10.1177/1087057106288220 Peer Reviewed verified by ORBi |
Tassin, A., Sauvage, S., Mattéotti, C., Van Acker, A.-M., Figlewicz, D., Padberg, G. W., Oberdan, L., Coppée, F., & Belayew, A. (25 October 2005). Studies on the expression of the DUX4 and DUX4c proteins [Poster presentation]. FSHD International Consortium Research Meeting, Salt Lake City, United States - Utah. |
Laoudj-Chenivesse, D., Barro, M., Sauvage, S., Tassin, A., Ansseau, E., Marcowycz, A., Figlewicz, D., Van Acker, A.-M., Leo, O., Belayew, A., & Coppée, F. (25 October 2005). Overexpression of the double homeodomain protein DUX4c in FSHD muscle [Paper presentation]. FSHD International Consortium Research Meeting, Salt Lake City, United States - Utah. |
Belayew, A., Ansseau, E., Sauvage, S., Marcowycz, A., Laoudj-Chenivesse, D., Carnac, G., Mattéotti, C., Gerbaux, C., Mahieu, I., Zorbo, S., Leclercq, I., Tassin, A., Figlewicz, D., & Coppée, F. (09 June 2005). Etude fonctionnelle de DUX4 et DUX4c, et de leur rôle dans la dystrophie de Landouzy-Dejerine [Paper presentation]. Meeting « Club Muscle IV », Marseille, France. |
Ansseau, E., Sauvage, S., Laoudj-Chenivesse, D., Carnac, G., Marcowyzc, A., Leroy, A., Leclercq, I., Figlewicz, D., Belayew, A., & Coppée, F. (27 May 2005). Characterization of DUX4c, a double homeobox gene located in a truncated and inverted D4Z4 element, and its expression in FSHD mlyoblasts [Poster presentation]. 190th meeting of the Belgian Society of Biochemistry and Molecular Biology, Mons, Belgium. |
Ansseau, E., Sauvage, S., Laoudj-Chenivesse, D., Carnac, G., Marcowycz, A., Leroy, A., Leclercq, I., Figlewicz, D., Belayew, A., & Coppée, F. (09 May 2005). Characterization of DUX4c, a double homeobox gene located in a truncated and inverted D4Z4 element, and its expression in FSHD mlyoblasts [Poster presentation]. Congrès Myologie 2005, Nantes, France. |
Ansseau, E., Coppée, F., D'Amico, E., Marcowycz, A., Mattéotti, C., Sauvage, S., Wiilocq, J., & Belayew, A. (26 October 2004). Functional study of the DUX4 and DUX4c genes [Paper presentation]. FSHD International Consortium Research Meeting, Toronto, Canada. |
Coppée, F., Mattéotti, C., Ansseau, E., Sauvage, S., Leclercq, I., Leroy, A., Marcowyzc, A., Gerbaux, C., Figlewicz, D., Ding, H., & Belayew, A. (2004). The DUX gene family and FSHD. In Facioscapulohumeral Muscular Dystrophy: Clinical Medicine and Molecular Biology (pp. 117-134). Bios. Scientific publisher. |
Ansseau, E., Coppée, F., & Belayew, A. (2003). Publication of a sequence in GeneBank 'accession num. EMBL/Genbank: AY500824 :Homo sapiens double homeobox4c (DUX4c) gene, complete cds'. |
 | Marcowyzc, A., Ansseau, E., Sauvage, S., Mattéotti, C., Zorbo, S., Belayew, A., & Coppée, F. (04 November 2003). Characterization of DUX4c and its role in facioscapulohumeral dystrophy (FSHD) [Poster presentation]. FSHD International Consortium Research Meeting, Los Angeles, United States. |
 | Ansseau, E., Coppée, F., & Belayew, A. (01 October 2003). Etude de l'élément cis répresseur du locus D4Z4 et de son rôle dans l'expression de DUX4, un gène candidat pour la dystrophie facio-scapulo-humérale (FSHD) [Poster presentation]. 1ère journées annuelles de Société Française de Myologie, Caen, France. |
 | Marcowycz, A., Ansseau, E., Coppée, F., & Belayew, A. (01 October 2003). Caractérisation du gène et de la protéine DUX4c [Paper presentation]. 1ère journées annuelles de la société française de Myologie, Caen, France. |
Ansseau, E., Sauvage, S., Mattéotti, C., Marcowyzc, A., Belayew, A., & Coppée, F. (30 September 2003). Functional study of the DUX4 gene [Poster presentation]. FSHD International Consortium Research Meeting, Los Angeles, United States. |
 | Gerard, A.-C., Denef, J.-F., Many, M.-C., Gathy, P., de Burbure, C., van den Hove, M.-F., Coppée, F., Ledent, C., & Colin, I.-M. (01 May 2003). Relationships between cell division, expression of growth factors and microcirculation in the thyroids of Tg-A2aR transgenic mice and patients with Graves' disease. Journal of Endocrinology, 177, 269-277. Peer Reviewed verified by ORBi |
Coppée, F., Ledent, C., Clement, S., Dessars, B., Goffart, J. C., Parma, J., Parmentier, M., Schurmans, S., & Dumont, J. E. (1999). Transgenic models of thyroid tumorigenesis: relation to Chernobyl cancers. In Radiation and Thyroid Cancer (pp. 239-249). Word Scientific Publishing. |
Seret, A., Schoutens, A., Blocklet, D., Moreno-Reyes, R., Coppée, F., Van Hove, C., & Defrise, M. (06 May 1999). Pinhole SPECT of small animals using vendor standard equipment [Paper presentation]. Symposium 'Frontiers in Nuclear Medecine Technology', Mol, Belgium. |
Coppée, F., & Dessart, B. (25 September 1998). Expression of the cyclin-cdk complexes inhibitors (CKI) in proliferative thyroid pathologies of transgenic mice [Poster presentation]. Hormones et régulation cellulaire, XXIIIe Symposium Européen du Mont Sainte-Odile, Sainte-Odile, France. |
 | Coppée, F., Deporteere, F., Bartek, J., Ledent, C., Dumont, J. E., & Parmentier, M. (06 August 1998). Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours. Oncogene, 17, 631-641. Peer Reviewed verified by ORBi |
van den Hove, M.-F., Legssyer, R., Couvreur, M., Gerard, A.-C., Coppée, F., & Ledent, C. (22 March 1997). Thyroid expression of an A2 adenosine receptor induces iodine accumulation in light lysosomes [Paper presentation]. ECBO, Brighton , United States. |
Uyttersprot, N., Allgeier, A., Baptist, M., Christophe, D., Coppée, F., Coulonval, K., Deleu, S., Depoortere, F., Dremier, S., Lamy, F., Ledent, C., Maenhaut, C., Miot, F., Panneels, V., Parma, J., Parmentier, M., Pirson, I., Pohl, V., Roger, P., ... Dumont, J. E. (1997). The cAMP pathway in thyroid: from the TSH receptor to mitogenesis and tumorigenesis. Signal Transduction in Health and Disease, Advances in Second Messenger and Phosphoproteins Research. In Advances in Second Messenger and Phosphoproteins Research (pp. 125-140). Greengard & Nairn & Shenolikar & Corbin Francis. |
Dremier, S., Coppée, F., Delange, F., Vassart, G., Dumont, J. E., & Van Sande, J. (01 December 1996). Thyroid autonomy: mechanism and clinical effects. Journal of Clinical Endocrinology and Metabolism, 81, 4187-4193. Peer Reviewed verified by ORBi |
Coppée, F. (13 November 1996). Apparition précoce de métastases différenciées à partir de carcinomes thyroïdiens chez des souris transgéniques exprimant le récepteur adénosine A2a et l'oncogène E7 de HPV16 [Paper presentation]. Séminaire d'histologie, UCL, Bruxelles, Belgium. |
Coppée, F., Gérard, A.-C., Denef, J.-F., Ledent, C., Vassart, G., Dumont, J. E., & Parmentier, M. (03 October 1996). Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene. Oncogene, 13, 1471-1482. Peer Reviewed verified by ORBi |
Dumont, J. E., Coulonval, K., Lamy, F., Van Sande, J., Parma, J., Dremier, S., Ledent, C., Coppée, F., & Savonet, V. (28 May 1996). Control of thyroid function and growth: cell division induced by cAMP is conditional on cell hypertrophy induced by IGF-1 [Paper presentation]. 19th National Endocrinology Diabetes and Endocrine Surgery Congress, Istanbul, Turkey. |
Ledent, C., Coppée, F., Dumont, J. E., Vassart, G., & Parmentier, M. (01 January 1996). Transgenic models for proliferative and hyperfunctional thyroid diseases. Experimental and Clinical Endocrinology and Diabetes, 104 (3), 43-46. Peer Reviewed verified by ORBi |
Dumont, J. E., Ermans, A. M., Maenhaut, C., Coppée, F., & Stanbury, J. B. (01 July 1995). Large goiter as a maladaptation to iodine deficiency. Clinical Endocrinology, 43 (1), 1-10. Peer Reviewed verified by ORBi |
Dumont, J. E., Ermans, A. M., Maenhaut, C., Coppée, F., & Stanbury, J. B. (01 July 1995). Large goitre as a maladaptation to iodine deficiency. Clinical Endocrinology, 43, 1-10. Peer Reviewed verified by ORBi |
Coppée, F. (01 February 1995). Caractérisation de souris transgéniques exprimant le récepteur adénosine A2a et l'oncogène E7 de HPV16 dans la thyroïde [Paper presentation]. Conférence Erasme, Bruxelles, Belgium. |
Coppée, F., Ledent, C., Dumont, J. E., Vassart, G., & Parmentier, M. (21 January 1995). Coexpression of two oncogenes results in the development of transgenic model for metastatic differentiated thyroid carcinoma [Poster presentation]. - Association Belge pour la recherche sur le cancer 'A.B.E.C.', Campus Erasme, ULB, Belgium. |
Ledent, C., Coppée, F., & Parmentier, M. (01 September 1994). Transgenic models of metastatic differentiated thyroid carcinomas [Paper presentation]. European Thyroid Association, Vienne, Austria. |
Ledent, C., Coppée, F., Dumont, J. E., Vassart, G., & Parmentier, M. (01 September 1994). Reconstruction of thyroid malignant phenotype in transgenic animals [Paper presentation]. European Thyroid Association, Vienne, Austria. |
